Shoreline Biosciences Finds $140M
socalTECH
NOVEMBER 2, 2021
San Diego-based Shoreline Biosciences, a developer of cell immunotherapies for treating solid tumors and hematologic malignancies, has raised $140M in a financing round, the company said today.
Let's personalize your content